Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

GE Healthcare is the healthcare division of the American multinational conglomerate, General Electric (NYSE: GE). The division alone is valued at US$16.7 billion and provides medical technology and related digital solutions on a global scale. ...

Summary NYSE listed Merck acquired VelosBio, a portfolio company of Arix Bioscience for US$2.75 billion Arix’s investment in VelosBio grew by 12 times Merck acquired VelosBio to bolster its oncology pipeline The global venture capit...

Summary TFF Pharmaceuticals Inc. was incorporated in 2018 as a clinical-stage biopharmaceutical company The company’s patented technology platform, Thin Film Freezing, or TFF helps it in developing and commercializing innovative drug prod...

Summary LiDCO Group Plc witnessed sales growth of 75% year-on-year during H1 FY21. The Company is getting acquired by Masimo Corporation. TomCo Energy Plc's POSP is expected to be operational by November 2020. The estimated capital cost for a...

Summary The UK’s Medicines and Healthcare Products Regulatory Agency has started the rolling review of AstraZeneca’s potential Covid- 19 vaccine, paving the way for its early roll-out The company had given an earlier roll-out schedu...

Summary GlaxoSmithKline Plc reported a revenue decline of 8% for Q3 FY20 The Company partnered with COVAX to provide 200 million doses of Covid-19 vaccine. Ibstock Plc has reported a revenue of 88% of last year in Q3 FY20. The Company expects...

Summary Boots will roll out new LumiraDx devices with the help of which the swab test Covid-19 results can be processed in just 12 minutes Boots will be launching a designated pre-flight Covid-19 testing service with the results of the test typ...

Summary Drugmakers AstraZeneca and Johnson & Johnson will resume their clinical trials in the US from this week The Food and Drug Administration on Friday authorised AstraZeneca to restart their trial in the US Johnson & Johnson said t...

Summary Pfizer said that after receiving the necessary approvals, stacks of its Covid-19 vaccine would be ready for dispatch from its production unit. An emergency approval for Pfizer’s vaccine would be sought in the US in November 2020 ...

Sector such as the health care tends to perform well during recessions, and stocks of these sectors offer great returns even in challenging times like the present Covid-19 pandemic scenario. The healthcare sector has become more relevant than ever ...